This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a trifluoromethyl group and a dihydropyrido[3,4-d]pyrimidine core, makes it valuable for creating potential drug candidates targeting various diseases, including cancer and neurological disorders. The tert-butyl ester group enhances its stability and reactivity, facilitating its use in complex organic transformations. Additionally, it is employed in medicinal chemistry for the design and optimization of small-molecule inhibitors, particularly in the development of kinase inhibitors, which are crucial in cancer therapy. Its unique chemical properties also make it a useful building block in the exploration of novel therapeutic agents.